We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
-$14.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
1.3 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
3.8 quarters
Top 10 Avg Time Held Equity only
1.3 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Buys

Rank Stock Value
1
DFS icon
Discover Financial Services
DFS
+$191M
2
SMAR icon
Smartsheet Inc.
SMAR
+$188M
3
FYBR icon
Frontier Communications
FYBR
+$124M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR icon
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT icon
CATALENT, INC.
CTLT
+$234M
2
MRO icon
Marathon Oil Corporation
MRO
+$222M
3
SRCL icon
Stericycle Inc
SRCL
+$172M
4
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT icon
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ABBV icon
201
AbbVie
ABBV
$489B
$1.33M 0.03%
7,488
+6,342
+553% +$1.17M
2022 Q3
9 quarters
ADPT icon
202
Adaptive Biotechnologies
ADPT
$4.23B
$1.28M 0.03%
213,829
+48,555
+29% +$268K
2022 Q1
11 quarters
KALA icon
203
KALA BIO
KALA
$5.68M
$1.24M 0.03%
3,579
+326
+10% +$103K
2024 Q1
3 quarters
AFYA icon
204
Afya
AFYA
$1.31B
$1.24M 0.03%
77,815
+16,918
+28% +$279K
2024 Q3
1 quarter
SNDX icon
205
Syndax Pharmaceuticals
SNDX
$1.52B
$1.19M 0.03%
90,232
+751
+0.8% +$12.9K
2023 Q4
4 quarters
ALC icon
206
Alcon
ALC
$31B
$1.19M 0.03%
14,039
+2,030
+17% +$183K
2024 Q1
3 quarters
ATXS icon
207
DELISTED
Astria Therapeutics
ATXS
$1.16M 0.03%
129,666
+5,464
+4% +$58K
2023 Q2
6 quarters
RCUS icon
208
Arcus Biosciences
RCUS
$3.11B
$1.14M 0.03%
76,646
+44,784
+141% +$731K
2022 Q2
10 quarters
ALLK icon
209
DELISTED
Allakos
ALLK
$1.13M 0.03%
936,797
+159,095
+20% +$167K
2024 Q1
3 quarters
BCYC icon
210
Bicycle Therapeutics
BCYC
$272M
$1.12M 0.03%
80,236
+44,260
+123% +$949K
2022 Q1
11 quarters
MLTX icon
211
MoonLake Immunotherapeutics
MLTX
$921M
$1.12M 0.03%
20,740
+4,740
+30% +$242K
2024 Q3
1 quarter
AURA icon
212
Aura Biosciences
AURA
$678M
$1.12M 0.03%
136,516
+29,618
+28% +$279K
2023 Q2
6 quarters
IOVA icon
213
Iovance Biotherapeutics
IOVA
$6.62B
$1.11M 0.03%
149,913
+36,136
+32% +$335K
2024 Q3
1 quarter
ALCY icon
214
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$1.1M 0.03%
100,248
– –
2024 Q1
3 quarters
ARQT icon
215
Arcutis Biotherapeutics
ARQT
$3.34B
$1.08M 0.03%
77,555
-14,464
-16% -$158K
2024 Q3
1 quarter
HYAC icon
216
DELISTED
Haymaker Acquisition Corp 4
HYAC
$1.08M 0.03%
100,248
– –
2023 Q3
5 quarters
MIRM icon
217
Mirum Pharmaceuticals
MIRM
$5.58B
$1.04M 0.03%
25,059
+8,521
+52% +$355K
2023 Q2
6 quarters
BOX icon
218
Box
BOX
$4.99B
$1.03M 0.03%
+32,500
New +$1.07M
2024 Q4
0 quarters
KPTI icon
219
Karyopharm Therapeutics
KPTI
$13.7M
$1M 0.02%
98,915
+19,170
+24% +$232K
2022 Q1
11 quarters
SKIL icon
220
Skillsoft
SKIL
$55.6M
$999K 0.02%
41,692
– –
2023 Q4
4 quarters
LION icon
221
Lionsgate Studios
LION
$3.31B
$994K 0.02%
130,774
– –
2024 Q2
2 quarters
BAX icon
222
Baxter International
BAX
$12.6B
$980K 0.02%
33,604
-8,939
-21% -$301K
2023 Q4
4 quarters
SONO icon
223
Sonos
SONO
$2.04B
$978K 0.02%
+65,000
New +$875K
2024 Q4
0 quarters
ITOS icon
224
DELISTED
iTeos Therapeutics
ITOS
$965K 0.02%
125,589
+59,649
+90% +$513K
2024 Q2
2 quarters
BLCO icon
225
Bausch + Lomb
BLCO
$6.18B
$947K 0.02%
52,460
+13,460
+35% +$263K
2024 Q3
1 quarter
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.